If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAJ Bell Regulatory News (AJB)

Share Price Information for AJ Bell (AJB)

Share Price is delayed by 15 minutes
Get Live Data
636.00    5.00 (0.79%)
Bid:
636.50
Ask:
638.50
Spread: 2.00 (0.314%)
Market Cap: £2.51b
AJB Live PriceLast checked at - London Stock Exchange

Intraday AJ Bell Share Chart

Directorate Change

30 Apr 2024 16:09

RNS Number : 6699M
AJ Bell PLC
30 April 2024
 

 

30 April 2024

AJ Bell plc ('AJ Bell' or 'Company')

 

Appointment of non-executive director

 

AJ Bell, one of the UK's largest investment platforms, is pleased to announce that Julie Chakraverty has been appointed to its Board of Directors as an independent non-executive director with effect from 1 June 2024.

 

Julie, a highly experienced non-executive director, brings more than 30 years of financial services and technology leadership experience to the Board. She spent most of her early career at UBS where she held multiple global leadership roles.

 

Julie is also the founder of Rungway Limited, an employee engagement platform that empowers people to seek and share advice at work. Julie is currently a non-executive director and Chair of the Ethics and Sustainability Committee at Starling Bank and the senior independent director and Chair of the Cyber Security Committee at NCC Group plc. Julie previously served on the Boards of Santander UK plc, Aberdeen Asset Management and Standard Life Aberdeen plc (now Abrdn plc), Amlin plc (now Mitsui Amlin), and the Spirit Pub Company plc (now Greene King).

 

Commenting on today's announcement, Fiona Clutterbuck, Chair of AJ Bell, said:

 

"I am very pleased to welcome Julie to the AJ Bell Board and look forward to working with her. Her wealth of experience in the financial services, consumer and cyber sectors will be invaluable to the Board as we continue to focus on our strategic priorities."

 

Commenting on her appointment, Julie Chakraverty said:

 

"I am delighted to be joining the talented team at AJ Bell to support their continued success and their impressive pace of product innovation. The business is in a strong position having recently surpassed half a million platform customers for the first time, an exciting milestone for the business and one which reflects the appeal of its low-cost, easy to use proposition. Its dual-channel model has provided a strong foundation for the business, delivering sustained organic growth. I am excited to work with Fiona, the Board and the executive team to take that growth strategy forward."

 

 

There is no other information regarding the appointment to be disclosed under paragraph 9.6.13R of the Listing Rules.

 

Contacts:

 

AJ Bell

 

· Shaun Yates, Investor Relations Director +44 (0) 7522 235 898

· Mike Glenister, PR Director +44 (0) 7719 554 575

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEASLEDEPLEFA
Date   Source Headline
30th Jun 20264:22 pmRNSTotal Voting Rights
29th Jun 20263:38 pmRNSTransaction in Own Shares
26th Jun 20269:31 amRNSDirector/PDMR Shareholding
23rd Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20264:22 pmRNSTransaction in Own Shares
12th Jun 20261:45 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSTotal Voting Rights
28th May 202610:41 amRNSBlock Admission Application
22nd May 20264:12 pmRNSDirector/PDMR Shareholding
22nd May 20269:32 amRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSInterim Results
13th May 20263:21 pmRNSDirector/PDMR Shareholding
30th Apr 20263:58 pmRNSTotal Voting Rights
27th Apr 20264:00 pmRNSTransaction in Own Shares
23rd Apr 20268:59 amRNSDirectorate change
23rd Apr 20267:00 amRNSQ2 Trading Update
20th Apr 202611:00 amRNSTransaction in Own Shares
15th Apr 202610:16 amRNSDirector/PDMR Shareholding
14th Apr 20263:03 pmRNSDirector/PDMR Shareholding
13th Apr 20263:00 pmRNSTransaction in Own Shares
7th Apr 20264:00 pmRNSTransaction in Own Shares
31st Mar 20261:35 pmRNSTotal Voting Rights
30th Mar 20262:00 pmRNSTransaction in Own Shares
27th Mar 20262:39 pmRNSDirector/PDMR Shareholding
16th Mar 20264:22 pmRNSTransaction in Own Shares
13th Mar 202611:46 amRNSDirector/PDMR Shareholding
13th Mar 202611:46 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20264:23 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20268:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20268:24 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20269:50 amRNSDirector/PDMR Shareholding
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.